The effects of neoadjuvant therapy on morbidity and mortality of esophagectomy for esophageal cancer: American college of surgeons national surgical quality improvement program (ACS –NSQIP) 2005–2012

ConclusionsWe conclude that neoadjuvant therapy followed by esophagectomy for esophageal cancer does not have a negative impact on 30‐day mortality. Neoadjuvant therapy is associated with increased odds of PE. J. Surg. Oncol. © 2016 Wiley Periodicals, Inc.

Source: Journal of Surgical Oncology - November 3, 2016 Category: Cancer & Oncology Authors: Michel J. Sabra, Carmen Smotherman, Dale F. Kraemer, Michael S. Nussbaum, Joseph J. Tepas, Ziad T. Awad Tags: Research Article Source Type: research